Eli Lilly and Company and Novo Nordisk A/S have been expanding the indications of their drugs approved to treat obesity to add to the already huge income such products have generated.
Meanwhile, it is not just major firms like Roche Holding AG and Pfizer Inc. playing catch up, but biotechs like Zealand Pharma A/S and Structure Therapeutics,...
Parexel's chief strategy officer Kushal Gohil, executive vice-president, clinical data and digital services, Stephen Pyke, and EVP and managing director for India, Sanjay Vyas, spoke about generative artificial intelligence...